» Articles » PMID: 12044859

Vinpocetine Increases Cerebral Blood Flow and Oxygenation in Stroke Patients: a Near Infrared Spectroscopy and Transcranial Doppler Study

Overview
Specialty Radiology
Date 2002 Jun 5
PMID 12044859
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the effect of vinpocetine on cerebral blood flow (CBF) in the compromised circulation of a stroke affected hemisphere using transcranial Doppler (TCD) and near infrared spectroscopy (NIRS) methods.

Methods: 43 patients with ischemic stroke were randomized into vinpocetine (VP) and placebo group in a double blind, placebo-controlled study of the effect of a single-dose i.v. infusion of vinpocetine on cerebral blood perfusion and oxygenation. In the VP group 20 mg VP in 500 ml saline, in the placebo group 500 ml saline alone were administered. The concentrations of oxy-, reduced- and total hemoglobin were measured by NIRS frontolaterally on the side of lesion while the mean cerebral blood flow velocity (CBFV), the pulsatility index (PI) and Doppler spectral intensity (DSI) were monitored by TCD in the middle cerebral artery on the same side. Values were averaged for the first 5 min prior to the infusion and for the last 5 min of infusion and they were compared between groups.

Results: The concentration of all three chromophores increased during infusion in the VP group (mean dHbT = 1.03, CI(95) = 0.84, P = 0.058; mean dHbO = 0.92, CI(95) = 0.91, P = 0.071; mean dHb = 0.10, CI(95) = 0.21, P = 0.297). The HbT and HbO showed a substantially smaller increase in the placebo group (mean dHbT = 0.31, CI(95) = 0.74, P = 0.22; mean dHbO = 0.57, CI(95) = 0.80, P = 0.094) while the Hb decreased (mean dHb = -0.26, CI(95) = 0.29, P = 0.05). Comparing to the placebo group Hb increased significantly in the VP group (P = 0.027) while the increase of HbO and HbT did not reach the level of significance (P = 0.29 and 0.11). DSI showed a significantly larger increase in the VP than in placebo group (dDSI=25.8 CI(95)=8.8 [VP]; dDSI =3.3, CI(95) = 3.7 [Placebo], P < 0.005). The CBFV and PI did not differ significantly between groups. (dVm = 5.0+/-2.98 cm/s [VP], dVm = 4.1+/-2.57 cm/s [Placebo], P = 0.28; dPI = 0.08 [VP], dPI = 0.09 [Placebo]; P = 0.47).

Conclusion: VP increases cerebral perfusion and parenchymal oxygen extraction as well. The increased perfusion was indicated by NIRS and by TCD measurement of DSI while conventional velocity and pulsatility measurements failed to detect theses effects. NIRS is a sensitive, feasible method of measuring changes in regional blood flow and tissue oxygenation in the superficial cortex.

Citing Articles

Regulation of cerebral blood flow boosts precise brain targeting of vinpocetine-derived ionizable-lipidoid nanoparticles.

Bian X, Yang L, Jiang D, Grippin A, Ma Y, Wu S Nat Commun. 2024; 15(1):3987.

PMID: 38734698 PMC: 11088666. DOI: 10.1038/s41467-024-48461-4.


Synthesis and Activity Evaluation of Vinpocetine-Derived Indole Alkaloids.

Dong Z, Shi Y, Zheng L, Tian Y, Yang J, Wei Y Molecules. 2024; 29(1).

PMID: 38202595 PMC: 10779641. DOI: 10.3390/molecules29010014.


Updates of Recent Vinpocetine Research in Treating Cardiovascular Diseases.

Zhang C, Yan C J Cell Immunol. 2020; 2(5):211-219.

PMID: 32832931 PMC: 7437952.


The Mitochondrial Targets of Neuroprotective Drug Vinpocetine on Primary Neuron Cultures, Brain Capillary Endothelial Cells, Synaptosomes, and Brain Mitochondria.

Svab G, Doczi J, Gerencser A, Ambrus A, Gallyas F, Sumegi B Neurochem Res. 2019; 44(10):2435-2447.

PMID: 31535355 PMC: 6776483. DOI: 10.1007/s11064-019-02871-9.


Cerebral Blood Flow Response During Bolus Normal Saline Infusion After Ischemic Stroke.

Mullen M, Parthasarathy A, Zandieh A, Baker W, Mesquita R, Loomis C J Stroke Cerebrovasc Dis. 2019; 28(11):104294.

PMID: 31416759 PMC: 6823150. DOI: 10.1016/j.jstrokecerebrovasdis.2019.07.010.